Literature DB >> 24960472

MicroRNA regulation of cancer metabolism: role in tumour suppression.

Marco Tomasetti1, Lory Santarelli2, Jiri Neuzil3, Lanfeng Dong4.   

Abstract

Mitochondria are critical regulators of cell metabolism; thus, mitochondrial dysfunction is associated with many metabolic disorders, including cancer. Altered metabolism is a common property of cancer cells that exhibit enhanced capacity to 'ferment' glucose to pyruvate and then lactate, even in the presence of sufficient oxygen to support mitochondrial metabolism. Recently, it was reported that microRNAs (miRNAs) regulate important signalling pathways in mitochondria and many of these miRNAs are deregulated in various cancers. Different regulatory mechanisms can control miRNA expression at the genetic or epigenetic level, thus affecting the biogenetic machinery via recruitment of specific transcription factors. Metabolic reprogramming that cancer cells undergo during tumorigenesis offers a wide range of potential targets to impair tumour progression. MiRNAs participate in controlling cancer cell metabolism by regulating the expression of genes whose protein products either directly regulate metabolic machinery or indirectly modulate the expression of metabolic enzymes, serving as master regulators. Thus, modulation of the level of miRNAs may provide a new approach for the treatment of neoplastic diseases.
Copyright © 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.

Entities:  

Keywords:  Cancer bioenergetics; MicroRNA; Mitochondria; Tumour suppression

Mesh:

Substances:

Year:  2014        PMID: 24960472     DOI: 10.1016/j.mito.2014.06.004

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  18 in total

Review 1.  Interplay of mitochondrial metabolism and microRNAs.

Authors:  Julian Geiger; Louise T Dalgaard
Journal:  Cell Mol Life Sci       Date:  2016-08-25       Impact factor: 9.261

Review 2.  Mitochondrial determinants of cancer health disparities.

Authors:  Aaheli Roy Choudhury; Keshav K Singh
Journal:  Semin Cancer Biol       Date:  2017-05-06       Impact factor: 15.707

3.  MicroRNA-215 acts as a tumor suppressor in breast cancer by targeting AKT serine/threonine kinase 1.

Authors:  Jian Yao; Ping Zhang; Jin Li; Wei Xu
Journal:  Oncol Lett       Date:  2017-05-17       Impact factor: 2.967

Review 4.  Renal Carcinogenesis, Tumor Heterogeneity, and Reactive Oxygen Species: Tactics Evolved.

Authors:  Karthigayan Shanmugasundaram; Karen Block
Journal:  Antioxid Redox Signal       Date:  2016-07-27       Impact factor: 8.401

5.  miR-132 mediates a metabolic shift in prostate cancer cells by targeting Glut1.

Authors:  Wei Qu; Shi-Mei Ding; Gang Cao; She-Jiao Wang; Xiang-Hong Zheng; Guo-Hui Li
Journal:  FEBS Open Bio       Date:  2016-06-08       Impact factor: 2.693

6.  Subpathway-GMir: identifying miRNA-mediated metabolic subpathways by integrating condition-specific genes, microRNAs, and pathway topologies.

Authors:  Li Feng; Yanjun Xu; Yunpeng Zhang; Zeguo Sun; Junwei Han; Chunlong Zhang; Haixiu Yang; Desi Shang; Fei Su; Xinrui Shi; Shang Li; Chunquan Li; Xia Li
Journal:  Oncotarget       Date:  2015-11-17

Review 7.  Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy.

Authors:  Marco Tomasetti; Wan Lee; Lory Santarelli; Jiri Neuzil
Journal:  Exp Mol Med       Date:  2017-01-20       Impact factor: 8.718

8.  Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma.

Authors:  Binkui Li; Liru He; Dinglan Zuo; Wei He; Yongjin Wang; Yuanping Zhang; Wenwu Liu; Yunfei Yuan
Journal:  J Cancer       Date:  2017-03-12       Impact factor: 4.207

9.  Identification of a robust subpathway-based signature for acute myeloid leukemia prognosis using an miRNA integrated strategy.

Authors:  Huijuan Chang; Qiuying Gao; Wei Ding; Xueqin Qing
Journal:  PLoS One       Date:  2018-03-23       Impact factor: 3.240

10.  Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways.

Authors:  Thomas Thurnherr; Way-Champ Mah; Zhengdeng Lei; Yu Jin; Steven G Rozen; Caroline G Lee
Journal:  Sci Rep       Date:  2016-01-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.